Cytotoxic effects of rhenium (I) carbonyl complexes on prostate cancer cell lines

Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival

Volumn , Issue , 2009, Pages 323-362

  Orsa, Dejene K ^a   Nettles, Columbus R ^a   Pramanik, Saroj K ^a   Iwunze, Maurice O ^a   Greco, George E ^b   Krause, Jeanette A ^c   Mandal, Santosh K ^a  

^a MORGAN STATE UNIVERSITY   (United States)

^b GOUCHER COLLEGE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896236808     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (18)

1. Balk, P., Ko,Y. J. & Bubley, G. J. (2003). Biology of Prostate-Specific Antigen. J. Clinic. Oncol., 28 (2), 383-91.
2. 3. J. Organomet. Chem., 658, 88-93.
3. th ed. D. A. Williams, T. L. Lemke, (Eds.), Lippincott Williams and Wilkins: Baltimore, 924-51.
4. Guilhem, J., Pascard, C., Lehn, J. M. & Ziessel, R. (1989). Crystal and molecular structures of μ-Hydrido-bis[fac-(2,2'-Bipyridine)tricarbonylrhenium(I)]chloride, fac-(2,2'Bipyridine)- tricarbonylformatorhenium(I), and fac-(2,2'-Bipyridine)tricarbonyl(cyanotrihydroborato) -rhenium(I). J. Chem. Soc. Dalton Trans., 1449-1454.
5. Hall, M. D., Dolman, R. C. & Hambley, T. W. (2004). Platinum(IV) Anticancer Complexes, Metal Ions in Biological Systems A. Sigel, & H. Sigel (Eds.), Marcel Dekker: New York, vol. 42, 297-317.
6. 2. Inorg. Chem. Commun., 4, 602-605.
7. + cations. Inorg. Chem., 42, 4262-4264.
8. 3, where, L-L are chelated diphosphines and diimines, Frontiers in Organometallic Chemistry. M. A. Cato (Ed.), Nova Science Publishers: New York, 191-228.
9. Orsa, D. K., Haynes, G. K., Pramanik, S. J., Iwunze, M. O., Greco, G. E., Ho, D. M., Krause, J. A., Hill, D. A., Williams, R. J. & Mandal, S. K. (2008). The one-pot synthesis and the fluorescence and cytotoxicity studies of chlorotricarbonyl(a-diimine)rhenium(I), fac- (CO)3(a- diimine)ReCl, complexes. Inorg. Chem. Commun., 11, 1054-1056.
10. Orsa, D. K., Haynes, G. K., Pramanik, S. K., Iwunze, M. O., Greco, G. E., Krause, J. A., Ho, D. M., Williams, A.L., Hill, D.A., Mandal, S.K. (2007). Synthesis, characterization, and fluorescence and cytotoxicity studies of a tetrarhenium molecular rectangle. Inorg. Chem. Commun., 10, 821-824.
11. Pil, P. & Lippard, S. J. (1992). Cisplatin as an Anticancer Drug Encyclopedia of Cancer. J. R. Bertino (Ed.), Academic Press: San Diego, vol. 1, 392-410.
12. Rennie, J. (1996). Fact Sheet -Twelve Major Cancers, Scientific American, 275, 126-132.
13. Roth, B. J. (1996). New therapeutic agents for hormone-refractory prostate cancer. Semin Oncol., 23, 49-55.
14. Stufkens, D. J. & Vlcek, A. (1998). Ligand-dependent excited state behaviour of Re (I) and Ru (II) carbonyl-diimine complexes. Coord. Chem. Rev., 177, 127-179.
15. Wang, W., Yan, Y. K., Hor, T. S. A., Vittal, J. J., Wheaton, J. R. & Hall, I. H. (2002). Synthesis, X-ray structures, and cytotoxicity of rhenium(I) carbonyl2-(dimethylamino) ethoxide complexes. Polyhedron, 21(20), 1991-1999.
16. Weiss, R. B. & Christian, M. C. (1993). New cisplatin analogues in development. A review. Drugs, 46(3), 360-377.
17. Yan, Y. K., Cho, S. E., Shaffer, K. A., Rowell, J. E., Barnes, B. J. & Hall, I. H. (2000). Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells. Pharmazie, 55(4), 307-313.
18. Zhang, J., Vittal, J. J., Henderson, W., Wheaton, J. R., Hall, I. H., Hor, T. S. A. & Yan, Y. K. (2002). Tricarbonylrhenium(I) complexes of phosphine-derivatized amines, amino acids, and a model peptide: structures, solution behavior, and cytotoxicity. J. Organomet. Chem., 650, 123-132.